-
Product Insights
Hyperammonemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hyperammonemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperammonemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperammonemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hyperkalemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hyperkalemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperkalemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperkalemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperphenylalaninemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperphenylalaninemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hyperlipidemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperlipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperlipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Amyloidosis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Lactic Acidosis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Lactic Acidosis Global Clinical Trials Review, H1, 2016" provides an overview of Lactic Acidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Lactic Acidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hyperuricemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperuricemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Metabolic Acidosis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Metabolic Acidosis Global Clinical Trials Review, H1, 2016" provides an overview of Metabolic Acidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Metabolic Acidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cardiometabolic Disease Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Cardiometabolic Disease Global Clinical Trials Review, H1, 2017" provides an overview of Cardiometabolic Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiometabolic Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
EpiCast Report: Growth Hormone Deficiency – Epidemiology Forecast to 2026
GHD is an endocrine disorder characterized by the insufficient production of GH by the pituitary gland. GHD is more commonly seen in children, although it can develop during adulthood. GHD can be present from birth (congenital), or it can be secondary due to brain trauma (acquired). Generally, a child with GHD is born with normal size at birth, but has delayed rates of bone development and bone lengthening later on. Patients who acquire GHD later in life present with more...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.